{
  "patientId": "PR-LUNG-001",
  "demographics": {
    "name": "Patricia Rodriguez",
    "dob": "1955-09-10",
    "gender": "Female",
    "address": "456 Pine St, Rivertown, USA",
    "phone": "555-4567",
    "insurance": "Medicare Part B",
    "referringPhysician": "Dr. Alan Grant (Pulmonology)",
    "emergencyContact": "Carlos Rodriguez (Son) - 555-4568",
    "advanceDirectives": "Full Code",
    "supportServices": "Connected with Lung Cancer Alliance support group. Nutrition consult completed.",
    "mobility": "Ambulatory without assistance. ECOG Performance Status 1."
  },
  "diagnosis": {
    "primary": "Non-Small Cell Lung Cancer (NSCLC) - Squamous Cell Carcinoma",
    "location": "Right Upper Lobe (RUL)",
    "datePathologicDiagnosis": "2025-01-15 (CT-guided Biopsy)",
    "pathologicStage": "Stage IIIA (T2b N2 M0)",
    "symptomsAtPresentation": "Persistent cough, shortness of breath on exertion, and mild hemoptysis.",
    "pathologyFindings": [
      "CT-Guided Biopsy of RUL mass (01/15/2025): Moderately differentiated squamous cell carcinoma.",
      "EBUS-FNA of Station 4R lymph node (01/20/2025): Positive for metastatic squamous cell carcinoma.",
      "Molecular Panel: PD-L1 TPS 60%. EGFR/ALK/ROS1 negative."
    ],
    "priorTreatmentSummary": "Patient has received 2 cycles of induction chemotherapy (Carboplatin/Paclitaxel) with concurrent Pembrolizumab, completed 03/15/2025, with good partial response seen on post-chemo PET/CT.",
    "relevantHistory": "30-pack-year smoking history (quit 5 years ago). Mild COPD.",
    "baselineStatus": "ECOG 1. Post-induction chemo, cough has improved. Still has mild dyspnea on exertion."
  },
  "treatmentPlan": {
    "radOnc": "Dr. Evelyn Reed",
    "medOnc": "Dr. Ben Carter",
    "pulmonologist": "Dr. Alan Grant",
    "treatmentSite": "Right Upper Lobe Tumor and Mediastinal Lymph Nodes (4R, 7)",
    "intent": "Curative (Definitive radiation after induction chemo)",
    "modality": "Proton Beam Therapy (PBT)",
    "totalDose": "60 Gy (CGE)",
    "fractionation": "30 fx",
    "rtRxDetails": "60 Gy (CGE) in 30 fractions (2 Gy/fx) using Pencil Beam Scanning (PBS) proton therapy.",
    "targetVolumeSummary": "Consolidate response in the primary RUL tumor and involved mediastinal lymph nodes.",
    "techniqueSummary": "Intensity Modulated Proton Therapy (IMPT) to deliver a highly conformal dose distribution, minimizing dose to the uninvolved lung, heart, and esophagus.",
    "concurrentChemo": "Concurrent Pembrolizumab (Immunotherapy) to continue every 3 weeks during proton therapy.",
    "medications": [
      "Tylenol as needed for discomfort.",
      "Viscous Lidocaine / 'Magic Mouthwash' for anticipated esophagitis."
    ],
    "therapistAlerts": [
      "Proton Therapy - Strict adherence to IGRT and QA protocols is mandatory.",
      "Patient utilizes 4D-CT based motion management. Ensure gating system is active and tracking patient's breathing cycle correctly.",
      "Monitor for signs of esophagitis (difficulty swallowing) and pneumonitis (worsening cough, shortness of breath)."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "2025-03-25",
      "setupInstructions": "Supine, arms overhead in wing board. Immobilized with a custom Vac-Lok bag.",
      "immobilization": "Vac-Lok (full body), Wing Board",
      "referenceMarks": "Tattoos placed at isocenter reference.",
      "scanner": "Siemens Biograph Vision PET/CT (for Sim)",
      "ctNotes": "4D-CT simulation performed to capture tumor motion during the breathing cycle. An Average Intensity Projection (AIP) CT was generated for planning. Patient was coached on consistent, regular breathing and tolerated the scan well."
    },
    "dosimetry": {
      "planId": "PR-LUNG-PBT-01",
      "planStatus": "Final - Approved by Dr. Evelyn Reed (03/28/2025)",
      "rx": "60 Gy (CGE) / 30 fx",
      "technique": "Pencil Beam Scanning (PBS) / IMPT",
      "energy": "Protons",
      "tps": "Eclipse (Proton Module)",
      "algorithm": "Proton Convolution Superposition (PCS)",
      "constraints": "Mean Lung Dose < 18 Gy, Heart V30 < 25%, Esophagus max < 65 Gy. All constraints met.",
      "planNotes": "Robust optimization performed to account for setup and range uncertainties. Daily CBCT for initial alignment, with orthogonal X-rays to verify target position relative to spine. MUs may be adjusted based on results of weekly adaptive re-planning QA.",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "CBCT + Orthogonal X-ray Pair",
        "alignment": "Initial alignment to bony anatomy on CBCT, then verify tumor position against fiducials/spine on orthogonal pair.",
        "tolerances": "2 mm / 1 degree"
      },
      "qaChecks": [
        { "date": "2025-03-28", "type": "Patient-Specific Plan QA", "by": "Medical Physicist (JW)", "result": "Pass (Gamma >98% at 3%/2mm)" }
      ],
      "fieldDetails": [
        {
          "fieldName": "Anterior Oblique Field",
          "fieldSize": "Variable (scanned beam)",
          "gantryAngle": "45",
          "collimatorAngle": "0",
          "couchAngle": "0",
          "energy": "70-180 MeV (scanned)",
          "monitorUnits": 2250,
          "ssd": "100 cm"
        },
        {
          "fieldName": "Posterior Oblique Field",
          "fieldSize": "Variable (scanned beam)",
          "gantryAngle": "210",
          "collimatorAngle": "0",
          "couchAngle": "0",
          "energy": "80-210 MeV (scanned)",
          "monitorUnits": 1980,
          "ssd": "100 cm"
        }
      ],
      "imagingFields": []
    },
    "treatmentDelivery": {
      "fractions": [
        { "fractionNumber": 1, "totalFractions": 30, "date": "2025-04-01", "machine": "Proton Gantry 2", "therapistInitials": "CF, RS",
          "recordedFields": [{ "fieldName": "Anterior/Posterior Obliques", "deliveredMu": 4230 }],
          "setupVerification": "Tolerances Met", "imagingType": "CBCT / Orthogonal kV Pair", "igrtMatchQuality": "Excellent", "igrtApprovedBy": "ER (Physician)",
          "patientTolerance": "Good", "generalSideEffects": "None", "siteSpecificSideEffects": "None", "dailyNotes": "First proton fraction delivered. Patient tolerated well. Breathing pattern was stable."
        },
        { "fractionNumber": 15, "totalFractions": 30, "date": "2025-04-21", "machine": "Proton Gantry 2", "therapistInitials": "CF, RS",
          "recordedFields": [{ "fieldName": "Anterior/Posterior Obliques", "deliveredMu": 4230 }],
          "setupVerification": "Tolerances Met", "imagingType": "CBCT / Orthogonal kV Pair", "igrtMatchQuality": "Good", "igrtApprovedBy": "Therapist",
          "patientTolerance": "Fair", "generalSideEffects": "Mild fatigue", "siteSpecificSideEffects": "Grade 1 esophagitis (mild difficulty swallowing solids). Mild cough.", "dailyNotes": "OTV today. Esophagitis beginning as expected. Advised patient to start on magic mouthwash and stick to soft foods. Weekly QA plan review shows no need for adaptation yet."
        },
        { "fractionNumber": 30, "totalFractions": 30, "date": "2025-05-12", "machine": "Proton Gantry 2", "therapistInitials": "CF, RS",
          "recordedFields": [{ "fieldName": "Anterior/Posterior Obliques", "deliveredMu": 4230 }],
          "setupVerification": "Tolerances Met", "imagingType": "CBCT / Orthogonal kV Pair", "igrtMatchQuality": "Excellent", "igrtApprovedBy": "ER (Physician)",
          "patientTolerance": "Fair", "generalSideEffects": "Moderate fatigue", "siteSpecificSideEffects": "Grade 2 esophagitis, managed with medication. Persistent cough.", "dailyNotes": "Final fraction completed. Patient relieved. Esophagitis peaked last week and is stable. Follow-up PET/CT scheduled in 3 months."
        }
      ]
    }
  },
  "imagingAndReports": [
    { "date": "01-10-2025", "type": "Diagnostic PET/CT Report", "summary": "Hypermetabolic 3.5 cm mass in the right upper lobe (SUVmax 12.5). Hypermetabolic right paratracheal (4R, SUVmax 8.9) and subcarinal (7, SUVmax 6.5) lymph nodes. Findings consistent with Stage IIIA NSCLC.", "reportDetails": {} }
  ],
  "dicomImages": [
    { "description": "Diagnostic PET/CT (01/10/2025)", "seriesType": "PET/CT", "ohifViewerUrl": "" },
    { "description": "4D-CT Simulation (03/25/2025)", "seriesType": "CT", "ohifViewerUrl": "" }
  ],
  "labResults": [
    { "date": "03/20/2025", "test": "Pulmonary Function Tests (PFTs)", "value": "FEV1 75% predicted, DLCO 68% predicted", "notes": "Mild obstructive defect, consistent with known COPD. Sufficient lung function for definitive chemoradiation." },
    { "date": "03/20/2025", "test": "CBC/CMP", "value": "WNL", "notes": "Counts recovered post-induction chemotherapy." }
  ],
  "progressNotes": [
    { "date": "01-25-2025", "author": "Dr. Alan Grant (Pulmonology)", "type": "Referral Note", "summary": "69yo F with new diagnosis of Stage IIIA squamous cell lung cancer after EBUS-guided staging. She is a candidate for curative-intent therapy. Referring to Medical Oncology and Radiation Oncology for combined modality treatment planning." },
    { "date": "03-20-2025", "author": "Dr. Evelyn Reed (Rad Onc)", "type": "Initial Consult", "summary": "Patient seen for definitive radiation planning after a good response to induction chemo. Given the tumor location and N2 disease, proton therapy is recommended to reduce dose to the heart and lungs compared to IMRT. We discussed the 6-week course of treatment, the use of concurrent immunotherapy, and potential side effects, focusing on esophagitis and pneumonitis. Patient understands and wishes to proceed with proton therapy. 4D-CT Sim scheduled." }
  ],
  "patientEducation": {
    "goalsDiscussed": "To deliver a curative dose of radiation to the lung tumor and involved lymph nodes while using protons to minimize radiation exposure to healthy surrounding organs, including the lungs, heart, and esophagus.",
    "sideEffectsReviewed": "Common: Fatigue, skin reaction at beam entrance, esophagitis (soreness or difficulty swallowing), and cough. Less common but serious: Pneumonitis (inflammation of the lungs), which can cause shortness of breath and may require steroids.",
    "safetyConsiderations": "Consistent, regular breathing is very important for this treatment, as the plan is designed around the tumor's movement. Daily imaging ensures accurate targeting. It is critical to report any new or worsening cough, shortness of breath, or difficulty swallowing.",
    "patientResponsibilities": "Attend all daily treatments. Follow breathing instructions. Report side effects to the team promptly."
  },
  "scheduling": [
    { "date": "03-20-2025", "type": "Radiation Oncology Consult", "status": "Completed" },
    { "date": "03-25-2025", "type": "4D-CT Simulation (Protons)", "status": "Completed" },
    { "date": "04-01-2025", "type": "Proton Therapy Start (Fx 1/30)", "status": "Completed" },
    { "date": "05-12-2025", "type": "Proton Therapy End (Fx 30/30)", "status": "Completed" },
    { "date": "08-12-2025", "type": "3-Month Post-RT Follow-up PET/CT", "status": "Scheduled" }
  ],
  "cptCharges": [
    { "code": "77290", "description": "Simulation, Complex", "frequency": "1" },
    { "code": "77338", "description": "IMRT/Proton planning", "frequency": "1" },
    { "code": "77301", "description": "IMRT plan", "frequency": "1" },
    { "code": "77523", "description": "Proton treatment delivery, intermediate", "frequency": "30" },
    { "code": "77387", "description": "Image Guided RT (IGRT)", "frequency": "30" },
    { "code": "77427", "description": "Radiation treatment management, 5 treatments", "frequency": "6" }
  ],
  "diagnosisSearch": "Lung Cancer, NSCLC, Proton Therapy, Squamous Cell Carcinoma, IMPT"
}
